Unite Us Receives Grant to Combat Ohio's Opioid Crisis and Expand Recovery Services in Montgomery County
Dayton, Ohio--(Newsfile Corp. - February 27, 2025) - Unite Us, the nation's leading technology partner for social care transformation, has been awarded a grant from the OneOhio Recovery Foundation to strengthen opioid abatement efforts in Montgomery County. This grant will enhance the Unite Ohio network, a statewide coordinated care network, to provide critical recovery services for residents of Ohio affected by opioid addiction.
Through a powerful partnership with CliniSync, Montgomery County Alcohol, Drug Addiction, and Mental Health Services (ADAMHS) and Unite Us, this initiative will use Unite Us' care coordination platform and data and analytics tools, to improve data sharing and connect healthcare providers, local government agencies, and community-based organizations (CBOs) to deliver timely, effective support to those in need. The technology will help ensure that individuals battling addiction receive the right care at the right time, streamlining recovery pathways.
'At Unite Us, we are dedicated to ensuring individuals facing addiction can access the care and support they need, when they need it,' said Taylor Justice, co-founder and president of Unite Us. 'This grant enables us to strengthen collaboration across healthcare and community organizations in Montgomery County, leveraging technology to remove barriers to recovery. By integrating our platform with CliniSync's Health Information Exchange, we can enhance data sharing, streamline care coordination, and improve outcomes for individuals and families impacted by the opioid crisis.'
A Proven Model for Success
The growth of Unite Ohio builds on a successful opioid reduction model launched in Summit County. Led by County Executive Ilene Shapiro in 2023, this initiative leveraged Opioid Use Disorder (OUD) settlement funds and has since become a statewide blueprint for technology-driven collaboration in addiction recovery.
The success of Unite Ohio has been greatly supported by key partners like CliniSync, MetroHealth, Cleveland Clinic, and Summit County. Their early adoption of Unite Us' technology has played a crucial role in establishing coordinated care solutions across the state. Their leadership continues to influence Ohio's comprehensive strategy for addressing the opioid crisis.
A Statewide Commitment to Recovery
This grant is part of the OneOhio Recovery Foundation's $51 million inaugural funding cycle, which supports statewide initiatives in prevention, treatment, and recovery. With funding requests far exceeding available resources, this partnership with Unite Us underscores the urgent need for scalable, tech-driven solutions to combat the opioid crisis.
'Across Ohio, organizations like Unite Us are working tirelessly to strengthen communities impacted by the opioid epidemic,' said Alisha Nelson, executive director of the OneOhio Recovery Foundation. 'We're pleased to partner with Unite Us to support their efforts to save lives, rebuild families affected by addiction, and foster strong and resilient places to live.'
For more details on the grant recipients and future funding opportunities, visit OneOhioFoundation.com/GrantAwards.
About Unite Us:
Unite Us is the nation's premier technology provider for transforming social care. Our advanced product suite is used to proactively coordinate services using data-driven insights, streamline referral and case management, and facilitate eligibility assessments and reimbursements across government, healthcare, health plans, and community organizations. The first of its kind, our closed-loop referral system prioritizes privacy and dignity and has integrated data and analytics tools used to measure impact, optimize programs, and shape policy. With over 1.5M services, we host the nation's largest network of community-based health and social services dedicated to improving whole-person health. Learn more at UniteUs.com and LinkedIn.
Media Contact:
About the OneOhio Recovery Foundation
The OneOhio Recovery Foundation is a private, non-profit foundation created under the leadership of Governor Mike DeWine and Attorney General Dave Yost, and other state and local leaders, with the mission of advancing Ohio's addiction prevention, treatment, and recovery efforts now and into the future.
The Foundation is governed by a 29-member board from across Ohio and is funded by 55 percent of settlement funds that Ohio is receiving from the pharmaceutical industry as a consequence of its role in the national opioid epidemic. Funds support local efforts to prevent and combat addiction and are also invested to support those efforts for the long term.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
a day ago
- Business Wire
Susan G. Komen ® To Host 2025 Northeast Ohio MORE THAN PINK Walk This September
CLEVELAND--(BUSINESS WIRE)-- Susan G. Komen ®, the world's leading breast cancer organization, will convene breast cancer survivors, those living with metastatic breast cancer (MBC) and supporters at the 2025 Susan G. Komen Northeast Ohio MORE THAN PINK Walk. This impactful event unites our community and raises money for the mission of Komen, supporting those affected by breast cancer. Komen aims to raise over $350,000 at the Northeast Ohio MORE THAN PINK Walk, generating critical funds that allow Komen to continue its investment in lifesaving work across the country, including promising research that will allow people to live longer lives with better outcomes. This event also funds Komen's Patient Care Center, a trusted, go-to source for timely, accurate breast health and breast cancer information, support and resources, as well as the work of Komen's Center for Public Policy to drive state and federal policies that invest in critical programs and ensure streamlined access to affordable, high-quality breast health care. WHEN: Saturday, September 20, 2025 WHERE: Wade Oval - 10820 East Blvd, Cleveland, OH 44106 WHY IT MATTERS: Breast cancer affects 1 in 8 women in the U.S. and 1 in 1,000 men in their lifetime. In 2025 alone, an estimated 316,950 women in the U.S. will be diagnosed with breast cancer and 42,170 women will die from the disease. Approximately 2,800 men will be diagnosed with breast cancer and 510 will die from it. However, some experts say one-third of breast cancer deaths in the U.S. could be prevented with universal access to modern treatments. In Ohio, approximately over 77,000 people will be diagnosed with breast cancer and over 24,000 will die from the disease this year. Susan G. Komen provides direct support to Ohioans through its Patient Care Center. In fiscal year 2025, Komen provided assistance to over 1,300 patients, including over $358,000 in financial assistance to eligible people in active treatment or living with metastatic breast cancer. 'The work Komen does for people with breast cancer, survivors and those with increased risk of breast cancer is not possible without the Northeast Ohio MORE THAN PINK Walk and the critical money we raise from our generous supporters,' said Sean Shacklett, executive director Ohio & Michigan at Susan G. Komen. 'We look forward to bringing together the Northeast Ohio community this fall and uniting around our goal of creating a world where we do not lose another life to this disease.' Bank of America is the national presenting sponsor and Lilly, Natera, and Novartis are national series sponsors for the MORE THAN PINK Walk and Race for the Cure events. About Susan G. Komen ® Susan G. Komen ® is the world's leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy's life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow's cures. Visit or call 1-877 GO KOMEN. Connect with us on social at
Axios
2 days ago
- Axios
Ohio's abortion wait times drop after pause on 24-hour law
Preterm Cleveland, the region's largest abortion provider, says its patients are getting care faster since Ohio's 24-hour waiting period was put on hold last year. Why it matters: The change has been especially significant for out-of-state patients, whose numbers have doubled since the U.S. Supreme Court overturned Roe v. Wade in 2022. 80% of those patients were seen in a single day over the past year, avoiding costly extended stays in Ohio, per Preterm. What they're saying: "There are so many financial and logistical barriers for patients seeking an abortion," said Bethany Lewis, executive director of Preterm, in a press release. "But the barriers increase exponentially the further you must travel for your appointment." By the numbers: New data from Preterm shows that 57% of patients in the past year have been able to receive counseling and an abortion on the same day. That's a dramatic shift from before the preliminary injunction, when state data showed most patients waited a week or more between appointments. State of play: Under the now-paused law, patients had to wait at least a day after counseling before receiving an abortion. Flashback: Ohioans voted in 2023 for the constitutional amendment that guarantees a right to an abortion.
Medscape
12-08-2025
- Medscape
Racial and Ethnic Inequities in OUD Care in the ED
TOPLINE: A new study revealed racial and ethnic disparities in access to opioid use disorder (OUD) treatment after emergency department (ED) visits, with Black and Hispanic individuals facing greater barriers than White individuals. METHODOLOGY: Researchers conducted a qualitative study between 2023 and 2024, involving in-depth telephone interviews with 57 adults with moderate-to-severe OUD who had previously participated in the ED-Innovation trial. The trial compared the effectiveness of sublingual buprenorphine vs 7-day injectable extended-release buprenorphine across 29 ED sites for formal addiction treatment engagement at day 7. Participants had a mean age of 41.7 years, and 35.1% were women. Of these, 35.1% were Black, 29.8% were Hispanic, and 35.1% were White. The telephonic interviews were developed using a combination of two frameworks: The National Institute on Minority Health and Health Disparities research framework and the theory of planned behavior. The outcome was the identification of barriers and facilitators at both behavioral and healthcare system levels associated with OUD treatment engagement across racial and ethnic groups. TAKEAWAY: Key facilitators included positive interactions with ED staff, stable access to healthcare, and supportive social networks, whereas common barriers included self-stigma, transportation issues, mental health concerns, and difficulty navigating the healthcare system. All racial groups acknowledged treatment initiation as a self-driven decision. White and Hispanic participants expressed concerns about buprenorphine's taste and adverse effects such as precipitated withdrawal, whereas Black participants did not share these concerns. Additionally, Hispanic participants reported inadequate dosing, and White participants noted unfulfilled formulation preferences and dental issues. Hispanic participants especially emphasized family support, whereas Black participants highlighted peer social support groups as crucial factors for treatment engagement. Black and Hispanic participants uniquely reported experiencing racism and mistrust toward the healthcare system outside their index ED visit, leading to barriers in accessing addiction treatment. IN PRACTICE: "Our findings underscore the need for holistic, culturally responsive care to address these distinct racial and ethnic factors influencing addiction care during and after ED visits," the authors wrote. "ED-based interventions should be patient-focused and low barrier (ie, greater flexibility) and should have strong health system and community support. ED substance use navigation, a program designed to help ED patients navigate structural barriers, is one potential solution," they added. SOURCE: The study was led by Edouard Coupet Jr, MD, MS, Yale School of Medicine, New Haven, Connecticut. It was published online on July 14, 2025, in JAMA Network Open. LIMITATIONS: Only English-speaking participants were included, limiting broader representation. Selection bias may have occurred due to the telephone interview format, potentially excluding individuals with disconnected phones or limited availability. All sites had prior experience in treating individuals with OUD, potentially limiting generalizability to less experienced settings. Matching by sex and location was challenging due to demographic clustering at some sites. Geographic location may have contributed to structural differences, potentially influencing responses. DISCLOSURES: The study was funded by the National Institute on Drug Abuse and Emergency Medicine Foundation. Some authors reported having financial or other ties with various sources. Further details are provided in the original article. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
